By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tonix Pharmaceuticals, Inc. 

509 Madison Ave.
Suite 306
New York  New York  10022  U.S.A.
Phone: 212-980-9155 Fax: 212-923-5700


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Tonix Pharma (TNXP) Receives European Patent For The Active Ingredient In Tonmya (Cyclobenzaprine HCL Sublingual Tablets) 9/15/2017 9:52:22 AM
Tonix Pharma (TNXP) Elects Margaret Smith Bell To The Board Of Directors 9/14/2017 10:09:17 AM
Tonix Pharma (TNXP) Presented Additional Phase II Clinical Results In Military-Related PTSD And Design Of Ongoing Phase III Trial At The 2017 Military Health System Research Symposium 8/30/2017 10:41:38 AM
Tonix Pharma (TNXP) To Present Additional Phase II Clinical Results And Design Of Ongoing Phase III Trial In Military-Related PTSD At The 2017 Military Health System Research Symposium 8/21/2017 10:10:06 AM
Tonix Pharma (TNXP) Announces Conditional Acceptance Of Tonmya As Proposed Brand Name For TNX-102 SL (Cyclobenzaprine HCL Sublingual Tablets) For The Treatment Of PTSD 7/6/2017 11:27:46 AM
Tonix Pharma (TNXP) Participated In The "Pathophysiology Of Posttraumatic Stress Disorder: Rethinking Drug Targets” Summit Sponsored By U.S. Department Of Defense 6/15/2017 11:04:39 AM
Tonix Pharma (TNXP) To Present An Update Of FDA Designated Breakthrough Therapy-TNX-102 SL For PTSD At The 2017 Marcum Microcap Conference 6/12/2017 12:05:02 PM
Tonix Pharma (TNXP) Presented Retrospective Analyses Of Treatment Response And Remission To TNX-102 SL In A Phase II Military-Related PTSD Study 5/31/2017 11:00:30 AM
Tonix Pharma (TNXP) To Present Additional Clinical Results Of Military-Related PTSD Study At The 2017 American Society Of Clinical Psychopharmacology Annual Meeting 5/24/2017 11:06:31 AM
Tonix Pharma (TNXP) Presented Analyses Of Potential Moderators Of Treatment Response To U.S. FDA-Designated Breakthrough Therapy For PTSD, TNX-102 SL, In Phase II AtEase Study In Military-Related PTSD 5/23/2017 8:42:15 AM
12345678910...
//-->